These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1173 related articles for article (PubMed ID: 32789471)
1. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature. Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471 [TBL] [Abstract][Full Text] [Related]
2. Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma. Wang X; Qiao J; Wang R Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111935 [TBL] [Abstract][Full Text] [Related]
3. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma. Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539 [TBL] [Abstract][Full Text] [Related]
4. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
5. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma. Li X; Lin J; Pan Y; Cui P; Xia J Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477 [No Abstract] [Full Text] [Related]
6. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Li L; Xie R; Lu G Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555 [TBL] [Abstract][Full Text] [Related]
7. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776 [TBL] [Abstract][Full Text] [Related]
8. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma. Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373 [TBL] [Abstract][Full Text] [Related]
9. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma. Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of immune-related gene signature models for predicting prognosis and immunotherapy response in hepatocellular carcinoma. Liu Z; Yang L; Liu C; Wang Z; Xu W; Lu J; Wang C; Xu X Front Immunol; 2024; 15():1371829. PubMed ID: 38933262 [TBL] [Abstract][Full Text] [Related]
11. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm. Yang Z; Zi Q; Xu K; Wang C; Chi Q Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739 [TBL] [Abstract][Full Text] [Related]
12. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma. Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387 [TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma. Chen W; Ou M; Tang D; Dai Y; Du W J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of a robust immune-related risk signature for hepatocellular carcinoma. Liu Z; Jiao D; Liu L; Zhou X; Yao Y; Li Z; Li J; Chen J; Lei Q; Han X Medicine (Baltimore); 2021 Mar; 100(10):e24683. PubMed ID: 33725827 [TBL] [Abstract][Full Text] [Related]
15. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma. Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474 [TBL] [Abstract][Full Text] [Related]
17. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis. Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412 [TBL] [Abstract][Full Text] [Related]
18. The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma. Li L; Xia S; Shi X; Chen X; Shang D Sci Rep; 2021 May; 11(1):10728. PubMed ID: 34021184 [TBL] [Abstract][Full Text] [Related]
19. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma. Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013 [TBL] [Abstract][Full Text] [Related]
20. Identification of a four-gene metabolic signature predicting overall survival for hepatocellular carcinoma. Liu GM; Xie WX; Zhang CY; Xu JW J Cell Physiol; 2020 Feb; 235(2):1624-1636. PubMed ID: 31309563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]